Storage Keep refrigerated (28C) to maintain potency and stability
Diabetic mice developed more severe infections, experienced greater weight loss and higher viral loads, and showed increased activity of a fibrosis-related gene not observed in non-diabetic mice
Bianchi R, Cervellini I, Porretta-Serapiglia C, Oggioni N, Burkey B, Ghezzi P, Cavaletti G, Lauria G (2012) Beneficial effects of PKF275-055, a novel, selective, orally bioavailable, long-acting dipeptidyl peptidase IV inhibitor in streptozotocin-induced diabetic peripheral neuropathy
Yet this minimalist architecture supports an unusually broad activity profile that has driven over four decades of research interest
FOXO4-DRI Also known as: FOXO4 D-Retro-Inverso, Proxofim Summary FOXO4-DRI is a senolytic peptide built in mirror-image (D-retro-inverso) form for stability, designed to kill senescent "zombie" cells by breaking the FOXO4-p53 interaction that keeps them alive